Although Israel is a small country of only 9.1 million it disproportionately contributes to research targeting treatments and hopefully someday cures for multiple myeloma. Multiple Myeloma in America About 13,000 Americans die every year from multiple myeloma...
Israel
Category
Israeli Academic Medical Centers Receive $4.3M in Research Funding from Israel Cancer Research Fund
The U.S.-based Israel Cancer Research Fund (ICRF), founded in 1975 by a group of American and Canadian medical researchers and oncologists, announced 69 grants worth $4.3 million to researchers at 10 different institutions including Ariel University, Bar-Ilan...
Israel’s Sheba Medical Center at the Forefront of Patient-Centric Oncology Engagement & Care Coordination
Sheba Medical Center of Israel, the nation’s largest hospital, collaborates with Telesofia Medical to offer tele-medicine solutions that support the communication between cancer patients with hospital doctors in dealing with the side effects of chemotherapy while the...
Ben-Gurion University Breakthrough Triggers Preclinical Commercialization of Natural Cancer-Killing Cells
Angel Porgador of Ben-Gurion University believes that “Natural killer cells” are the future of cancer treatments. A recent study reveals that proteins in the cell membranes of cancer inhibit the body’s immune system, actually supporting the cancer to proliferate—while...
Australian Foundation for Diabetes Research-Led Investigational Breakthrough Treatment for Diabetes Patients
The Israeli and New South Wales Australia governments are backing an Israeli clinical research venture called Kadimastem and the Australian Foundation for Diabetes Research’s Bioengineering Diabetes Therapy project seeking to remove the need for insulin injections and...
Breakthrough Pancreatic Cancer Treatment Phase III Trial Opens in Israel
Israel-based Rafael Pharmaceuticals launched a Phase 3 clinical trial on Thursday for pancreatic cancer at eight sites throughout Israel. Dr. Talia Golan leads the study as Principal Investigator. She heads the Sheba Medical Center’s Pancreatic Cancer Center. The...
Texas Medical Center Incubates and Houses Israeli Health Ventures
The Texas Medical Center in Houston, the world’s largest complex of providers in one metropolitan area, has partnered with Israel’s Start up Nation Central to incubate innovative new medical technologies for recent graduates of GiantLeap and DosentRX. With 56 member...
Israel and Argentina Launch Clinical Trials-Related Collaborative
Israel’s Innovation Authority (IIA) and Argentina’s Rosario Stock Exchange have launched a technology alliance involving private ventures from both countries. The IIA will allocate funds to the Israeli ventures to cooperate and co-develop significant technology...
FDA Grants Orphan Drug Designation to Israeli Investigative Treatment for Adenoid Cystic Carcinoma
Adenoid Cystic Carcinoma (ACC) is a rare form of cancer. Out of the approximately 566,000 diagnosed in the U.S. with cancer each year, about 1,224 individuals are diagnosed with ACC. The Adenoid Cystic Carcinoma Organization International reports that approximately...
Israeli Kitov Acquires FameWave
Kitov Pharma Ltd. (NASDAQ/TASE: KTOV) is an innovative pharmaceutical company developing first-in-class combination oncology therapies. Today they announced a key milestone in the acquisition of FameWave Ltd., following signature of a clinical collaboration agreement...
Sourasky Medical Centre to Execute Study for OWC Pharma
BiospectrumAsia reports OWC Pharmaceutical Research Corp. (the company transforming cannabis into scientifically proven and clinically approved medical solutions) announces an agreement with the Tel Aviv Sourasky Medical centre Fund. The medical centre will perform a...
EU & Canada Award 8.4 m. Euros to Bar-Illan University-Led Health Data Project
The Jerusalem Post reports that the EU and the Canadian government have awarded 8.3 million ($9.6 mil) euros to the Israeli—led international iReceptor Plus project to improve genomic and health-data sharing. Bar-Ilan University leads the iReceptor Plus consortium...
Sourasky Center Israel Drives Cannabis-based Pill Trial for Spasticity Treatment
Sourasky Academic Medical Center, Tel Aviv Israel, will drive a 2019 trial to evaluate the activity and safety of a cannabinoid-enriched sublingual soluble tablet. The study has been approved by an Israeli-based IRB. The trial’s sponsor, OWC Pharmaceutical Research,...
Tel Aviv Sourasky Med Center Israel Contributing to National Impacts
As reported in the Florida Jewish Journal by Maayan Jaffe-Hoffman, a business man partnered with an Israeli researcher from Tel Aviv Sourasky Medical Center to focus on new stem cell research. The pair thereafter founded Cellect Biotechnology to commercialize...
Alpha Tau Medical Partners with La Sapienza and IFO in Italy
Israel-based Alpha Tau Medical, developer of what they position as a breakthrough alpha-radiation cancer therapy, is initiating two new clinical trials with two leading medical centers in Rome Italy. Following IRB approval, La Sapienza is initiating Alpha Tau’s...
Sourasky Medical Center Israel Research Finds Cannabis Reduces Chronic Pain
As reported in China-based Xinhuanet, Tel Aviv-based Sagol Brian Institute and Chronic and Acute Pain Center Sourasky Medical Center researchers found that cannabis can reduce pain in patients suffering from chronic pain.
Is Israel the Great Disrupter in Cannabis Clinical Research?
World Israel News reports that global leaders gathered at the third annual cannabis conference in Tel Aviv, where it was evident that despite the growing cannabis industry in the U.S., federal limitations on clinical trials cause it to lag behind the innovative...
Cutting-Edge Cardiac Center to Ein Kerem Campus, Jerusalem, Israel
Times of Israel reports that a $10 million heart center at Hadassah’s Ein Kerem medical campus is doubling the Jerusalem hospital’s capacity to treat cardiac patients. Inaugurated on October 12, the Irma and Paul Milstein Heart Center occupies the entire third floor...
Israeli Cancer Diagnostic Ventures Secure Lucrative Chinese Deal
Eytan Halon of The Jerusalem Post reports that Tel Aviv-based Micromedic secures distribution deal with Chinese-based Shanghai Gensource Medical Applicances to more than 8,000 hospitals and medical centers. CEO Guy Lerner said “we are pleased by the first distribution...
Rambam Medical Center Partners with Georgia Institute of Technology for Medical Tech
Judy Siegel-Itzkovich writing for Breaking Israel News reports that a prominent Israeli and Georgia medical research center has come together to develop and commercialize new medical technology. The partnership will support an incubator for Israeli-based companies in...